# Septoplasty: defining a desirable clinical outcome according to baseline symptom scores

**Authors:** Rolf Haye, Liv Kari Døsen, Magnus TarAngen, Caryl Gay, Are Hugo Pripp, Olga Shiryaeva

PMC · DOI: 10.3389/fsurg.2025.1471526 · Frontiers in Surgery · 2025-02-12

## TL;DR

This study defines how much improvement in nasal obstruction scores after septoplasty is considered clinically meaningful, based on patients' initial symptom severity.

## Contribution

The study introduces a baseline-dependent desirable clinically important difference (DCID) to assess individual patient outcomes after septoplasty.

## Key findings

- DCID increases with baseline nasal obstruction severity: 27.5 (moderate), 44.5 (severe), and 56.0 (very severe).
- Relative DCID also increases with severity: 49.6% (moderate), 56.8% (severe), and 61.3% (very severe).
- A 49% improvement is considered clinically successful for moderate obstruction, while very severe cases require 61% improvement.

## Abstract

The results of septoplasty are usually reported as statistically significant improvements in baseline scores, but these may be difficult to interpret clinically. A measure called the desirable clinically important difference (DCID) has been developed to serve as a guideline to assist in clinically interpreting improvement in scores. So far, DCID has only been calculated for whole cohorts. As individual patients have different baseline and improvement scores, such measures are not helpful to individuals. Our aim was to establish a DCID according to baseline scores, which should help assess individual results.

Patients (n = 934) rated their nasal obstruction using a visual analog scale (VAS) preoperatively and 6 months postoperatively. A global rating of outcome (categorized as completely, much, or somewhat improved, unchanged, or worse) served as the anchor for postoperative evaluation. The improvement in VAS score corresponding to the “much improved” rating was defined as the borderline value between “much” and “somewhat improved.” Receiver operating characteristics were used to establish this borderline value. The DCID is the difference between the borderline and baseline VAS scores. The relative DCID is calculated by dividing the numeric DCID by the baseline VAS score. The cohort was divided into three subgroups (moderate, severe, very severe) according to preoperative severity of nasal obstruction (VAS score) for assessing the relation between DCID and baseline obstruction severity.

The DCID increased with increasing severity of baseline nasal obstruction: 27.5 (moderate), 44.5 (severe), and 56.0 (very severe), as did the relative DCID: 49.6% (moderate), 56.8% (severe), and 61.3% (very severe).

The relative DCID can be a guide for assessing improvement following septoplasty according to baseline scores of nasal obstruction and for planning surgery. A 49% improvement from baseline is indicative of clinical success for a patient with moderately obstructed nasal breathing, whereas patients with very severe obstruction require a 61% improvement.

## Full-text entities

- **Diseases:** nasal obstruction (MESH:D015508)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11860878/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC11860878/full.md

## References

15 references — full list in the complete paper: https://tomesphere.com/paper/PMC11860878/full.md

---
Source: https://tomesphere.com/paper/PMC11860878